The 1,000th TAVR, combined with a commitment to safety and quality outcomes, solidifies Doylestown as an elite structural ...
A revolutionary new medical procedure gaining traction in the UAE allows patients to bypass the need for traditional heart ...
The following is a summary of “Computed tomography derived predictors of left ventricular obstruction after TAVR,” published ...
An innovative heart procedure is changing the lives of patients with aortic valve disease. It's called transcatheter aortic ...
THE SOLVE-TAVI trial demonstrated that both valve type and anaesthesia strategy yielded comparable long-term outcomes in ...
Zuckerberg Sees ‘Opportunity To Restore Free Expression’ The analyst estimates that in the U.S., around 130,000 isolated aortic valve replacement (AVR) procedures are performed annually ...
North America to Lead Revenue While Asia Pacific Emerges as the Fastest-Growing Region, Driven by Rising Cardiovascular Cases ...
Lipoprotein(a) doesn’t influence calcification or outcomes in TAVR, shifting focus to other AS progression factors.
Barclays analyst Matt Miksic initiated coverage of Anteris Technologies (AVR) with an Overweight rating and $22 price target The timing for ...